Steven Helwig
Corporate Officer/Principal chez RADIUS HEALTH, INC.
Postes actifs de Steven Helwig
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 15/03/2022 | - |
| Comptroller/Controller/Auditor | 26/08/2021 | 15/03/2022 | |
| Directeur Financier/CFO | 01/08/2015 | 15/03/2022 | |
| Treasurer | 26/08/2021 | 15/03/2022 |
Historique de carrière de Steven Helwig
Statistiques
Internationale
| Etats-Unis | 2 |
Opérationnelle
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Steven Helwig
- Expérience
